By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pharming Group N.V. 

P.O. Box 451

AL Leiden    2300  The Netherlands
Phone: 31-0-71-524-7400 Fax: +31-0-71-521-6507


Company News
Pharming Group (PHGUF.PK) Reports On Financial Results For The First Six Months Of 2016 7/28/2016 10:46:53 AM
Pharming Group (PHGUF.PK) And CytoBioteck Announce Extension Of Distribution Agreement For Ruconest 2/9/2016 8:54:22 AM
Pharming Group (PHGUF.PK) Announces Completion Of Patient Enrolment In Clinical Study Of Ruconest For Prophylaxis Of Hereditary Angioedema 1/6/2016 9:25:57 AM
Pharming Group (PHGUF.PK) Release: European Medicines Agency Reaffirms Important Health Benefits And Safety Of Ruconest For Patients With Hereditairy Angioedema 12/7/2015 11:20:02 AM
Pharming Group (PHGUF.PK) Release: Interim Report January - September 2015 10/28/2015 11:48:34 AM
Pharming Group (PHGUF.PK) Nominates Mr Robin Wright As Chief Financial Officer 9/8/2015 10:38:44 AM
Pharming Group (PHGUF.PK) Reports On Financial Results First Half Year 2015 7/30/2015 9:08:24 AM
Pharming Group (PHGUF.PK) Release: HAEi Global Access Program for RUCONEST Now Live 7/21/2015 12:15:39 PM
Pharming Group (PHGUF.PK) Announces Us$17 Million (€15.6 Million) Straight Debt Financing 7/20/2015 9:35:46 AM
Pharming Group (PHGUF.PK) Announces Interim Results From The Ongoing Phase II Pediatric Clinical Trial Of Ruconest 6/1/2015 10:04:47 AM